Tissue Regenix raises 40 mln stg to buy U.S. regenerative medicine firm

LONDON, July 21 (Reuters) - Tissue Regenix said on Friday it had raised 40 million pounds ($52 million) by selling new shares to buy CellRight Technologies, a U.S regenerative medicine company that specialises in spine surgery and orthopaedics.

from Reuters: New Issues News http://ift.tt/2uGkHIT